Why are my gums and skin getting darker?

Darkening of gums and skin can result from increased melanin production triggered by hormonal changes, medications, sun exposure, or underlying health conditions. While often harmless, sudden or widespread changes warrant medical evaluation to rule out conditions like Addison's disease or hemochromatosis.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Hyperpigmentation: When Your Body Produces Extra Melanin

If you've noticed your gums or skin becoming darker, you're experiencing what medical professionals call hyperpigmentation. This condition occurs when your body produces excess melanin, the pigment responsible for your skin, hair, and eye color. While darkening can be concerning, it's often a benign response to various internal or external factors.

Hyperpigmentation can manifest in different ways: as patches on your face (melasma), spots on sun-exposed areas (solar lentigines), or even as darkening of your gums (gingival hyperpigmentation). Understanding the underlying cause is crucial for determining whether the changes are cosmetic or indicative of a health condition that needs attention.

Common Causes of Skin Darkening

Hormonal Changes and Melasma

Hormonal fluctuations are among the most common triggers for skin darkening, particularly in women. Pregnancy, often called the 'mask of pregnancy' when melasma occurs, can cause symmetric patches of darkened skin on the face. Birth control pills and hormone replacement therapy can similarly trigger hyperpigmentation by stimulating melanocyte activity.

Medical Conditions Associated with Hyperpigmentation

Early detection through appropriate testing can help identify treatable underlying conditions causing hyperpigmentation.
ConditionPattern of DarkeningAssociated SymptomsDiagnostic Tests
Addison's DiseaseAddison's DiseaseSkin creases, scars, gums, lipsFatigue, weight loss, low BP, salt cravingsCortisol, ACTH stimulation test
HemochromatosisHemochromatosisBronze/gray skin toneJoint pain, fatigue, diabetesFerritin, iron studies, genetic testing
MelasmaMelasmaSymmetric facial patchesNone (cosmetic only)Clinical examination, Wood's lamp
PCOSPCOSNeck, armpits (acanthosis nigricans)Irregular periods, hirsutismHormone panel, glucose testing

Early detection through appropriate testing can help identify treatable underlying conditions causing hyperpigmentation.

These hormonal influences affect approximately 90% of pregnant women to some degree, with the darkening typically appearing on the cheeks, forehead, upper lip, and nose. The condition often fades after pregnancy or discontinuation of hormonal medications, though some pigmentation may persist. If you're experiencing hormonal-related skin changes, monitoring your hormone levels through comprehensive testing can provide valuable insights into your body's balance.

Sun Exposure and Age Spots

Ultraviolet radiation from sun exposure is a primary driver of skin darkening. When UV rays penetrate your skin, they trigger melanocytes to produce more melanin as a protective mechanism. This process leads to tanning in the short term but can result in permanent dark spots (solar lentigines) with repeated exposure over years.

Age spots typically appear on areas most exposed to the sun: face, hands, shoulders, and arms. They're more common after age 50 but can appear earlier in people with significant sun exposure history. Unlike freckles, which fade in winter, age spots remain constant year-round.

Post-Inflammatory Hyperpigmentation

When your skin experiences trauma or inflammation, it may respond by producing excess melanin during the healing process. This post-inflammatory hyperpigmentation (PIH) can follow acne breakouts, cuts, burns, or even aggressive skincare treatments. People with darker skin tones are particularly susceptible to PIH due to higher baseline melanin levels.

Why Your Gums Are Getting Darker

Gum darkening, or gingival hyperpigmentation, can occur for several reasons. While some people naturally have darker gums due to genetic factors, changes in gum color can also signal underlying issues or external influences.

Genetic and Ethnic Factors

Melanin distribution in gums varies significantly among different ethnic groups. People of African, Asian, Mediterranean, or Middle Eastern descent often have naturally darker gums due to higher melanin concentrations. This physiological pigmentation is completely normal and doesn't indicate any health problems.

Smoking and Tobacco Use

Smoking is a major cause of acquired gum darkening, known as smoker's melanosis. The nicotine and tar in tobacco products stimulate melanocytes in the gum tissue, leading to patchy or diffuse darkening. This discoloration typically affects the anterior (front) gums more than posterior areas and can develop within months of regular smoking.

The good news is that smoking-related gum darkening is often reversible. Studies show that gum color can return to normal within 6-12 months after quitting tobacco use, though the timeline varies based on smoking duration and intensity.

Medical Conditions That Cause Darkening

While many causes of skin and gum darkening are benign, certain medical conditions can manifest through hyperpigmentation. Understanding these conditions helps determine when darkening warrants medical evaluation.

Addison's Disease

Addison's disease, a rare disorder affecting the adrenal glands, causes insufficient production of cortisol and aldosterone. One hallmark sign is hyperpigmentation, particularly in skin creases, scars, lips, and gums. The darkening occurs because low cortisol levels trigger the pituitary gland to produce more ACTH (adrenocorticotropic hormone), which stimulates melanin production.

Additional symptoms of Addison's disease include extreme fatigue, weight loss, low blood pressure, salt cravings, and muscle weakness. If you're experiencing widespread darkening along with these symptoms, immediate medical evaluation is essential. Regular monitoring of cortisol levels can help detect adrenal insufficiency early.

Hemochromatosis

Hemochromatosis causes excessive iron accumulation in the body, leading to a bronze or grayish skin discoloration. This genetic disorder affects iron metabolism, causing the mineral to deposit in various organs including the skin. The darkening typically has a metallic quality that distinguishes it from other forms of hyperpigmentation.

Early detection through ferritin and iron panel testing is crucial, as untreated hemochromatosis can damage the liver, heart, and pancreas. Treatment involves regular phlebotomy (blood removal) to reduce iron levels.

Peutz-Jeghers Syndrome

This rare genetic condition causes distinctive dark spots on the lips, inside the mouth, and on fingers and toes. The pigmentation typically appears in childhood and may fade with age. While the spots themselves are harmless, Peutz-Jeghers syndrome increases cancer risk, making regular screening important for affected individuals.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Medications That Can Darken Skin and Gums

Numerous medications can trigger hyperpigmentation as a side effect. Understanding medication-induced darkening helps differentiate it from other causes and informs discussions with healthcare providers about alternative treatments.

  • Antimalarials (chloroquine, hydroxychloroquine): Can cause blue-gray discoloration
  • Antibiotics (minocycline, tetracycline): May lead to gray-brown pigmentation
  • Chemotherapy drugs: Often cause diffuse darkening or specific nail/skin changes
  • Antipsychotics (chlorpromazine): Can result in sun-exposed area darkening
  • Anticonvulsants (phenytoin): May cause gum darkening and overgrowth
  • NSAIDs: Some can increase photosensitivity and subsequent pigmentation

Medication-induced hyperpigmentation typically develops gradually over weeks to months. The pattern and color of darkening can help identify the causative drug. Most cases improve after discontinuing the medication, though resolution can take months to years.

When to Seek Medical Attention

While gradual, symmetric darkening is often benign, certain patterns and accompanying symptoms warrant prompt medical evaluation. Knowing these warning signs helps distinguish cosmetic concerns from potential health issues.

Seek immediate medical attention if darkening is accompanied by unexplained weight loss, severe fatigue, persistent nausea, or changes in blood pressure. Sudden onset of widespread darkening, especially with systemic symptoms, requires urgent evaluation to rule out adrenal insufficiency or other endocrine disorders.

For isolated skin or gum darkening without other symptoms, schedule a routine appointment with your healthcare provider or dermatologist. They can perform a thorough examination, review your medications, and order appropriate tests if needed. If you want to understand your baseline health markers and identify any underlying imbalances, comprehensive biomarker testing provides valuable insights. You can also upload your existing blood test results to SiPhox Health's free analysis service for personalized interpretations and recommendations.

Diagnostic Tests and Evaluations

When evaluating unexplained hyperpigmentation, healthcare providers use various diagnostic tools to identify underlying causes. The diagnostic approach depends on the pattern of darkening and associated symptoms.

Blood Tests

  • Cortisol levels (morning and evening): Screens for adrenal insufficiency
  • ACTH stimulation test: Confirms Addison's disease diagnosis
  • Iron studies (ferritin, transferrin saturation): Detects hemochromatosis
  • Thyroid function tests: Rules out thyroid-related pigmentation changes
  • Complete blood count: Identifies anemia or other blood disorders
  • Comprehensive metabolic panel: Assesses overall organ function

Skin Examination Techniques

Dermatologists use Wood's lamp examination to enhance visualization of pigmentation patterns. This ultraviolet light makes epidermal pigmentation appear more pronounced while dermal pigmentation remains unchanged. Dermoscopy provides magnified views of pigmented lesions, helping distinguish benign changes from concerning patterns.

In some cases, skin biopsy may be necessary to examine pigmentation at the cellular level. This helps differentiate between increased melanin production, melanin deposits from medications, and other pigmentary disorders.

Treatment Options and Prevention Strategies

Treatment for hyperpigmentation varies based on the underlying cause, severity, and patient preferences. While some darkening resolves spontaneously, others require active intervention for improvement.

Topical Treatments

  • Hydroquinone (2-4%): Gold standard for lightening, requires careful monitoring
  • Tretinoin: Accelerates cell turnover and enhances other treatments
  • Vitamin C serums: Provides antioxidant protection and mild lightening
  • Kojic acid: Natural alternative that inhibits melanin production
  • Azelaic acid: Effective for post-inflammatory hyperpigmentation
  • Niacinamide: Reduces melanin transfer to skin cells

Combination therapies often work better than single agents. The Kligman formula, combining hydroquinone, tretinoin, and a corticosteroid, remains highly effective for stubborn hyperpigmentation. Treatment typically requires 3-6 months for noticeable improvement.

Professional Procedures

For resistant hyperpigmentation, dermatologists offer various procedures. Chemical peels using glycolic, salicylic, or trichloroacetic acid can improve superficial pigmentation. Laser treatments, including Q-switched lasers and fractional resurfacing, target deeper pigmentation but require careful selection based on skin type to avoid worsening hyperpigmentation.

Intense pulsed light (IPL) therapy effectively treats sun-induced pigmentation but may worsen melasma in some cases. Microneedling combined with topical agents enhances penetration and efficacy. For gum darkening, gingival depigmentation procedures using lasers or surgical techniques can provide dramatic improvement.

Prevention Strategies

Sun protection remains the cornerstone of preventing and managing hyperpigmentation. Daily broad-spectrum sunscreen with SPF 30 or higher is essential, even on cloudy days. Physical blockers containing zinc oxide or titanium dioxide are less likely to irritate sensitive skin.

  • Wear protective clothing and wide-brimmed hats during peak sun hours
  • Apply sunscreen 30 minutes before sun exposure and reapply every 2 hours
  • Use antioxidant serums to neutralize free radical damage
  • Avoid picking at skin or aggressive exfoliation that can trigger PIH
  • Manage underlying conditions that contribute to hyperpigmentation
  • Review medications with healthcare providers if darkening develops

Living with Hyperpigmentation: Long-term Management

Managing hyperpigmentation requires patience and consistency. Results from treatments take time, and maintenance therapy is often necessary to prevent recurrence. Establishing a comprehensive skincare routine tailored to your skin type and concerns provides the foundation for improvement.

Keep a photo diary to track changes over time, as gradual improvements can be difficult to notice day-to-day. Work with dermatologists experienced in treating your skin type, as treatment approaches vary significantly based on baseline pigmentation and tendency for post-inflammatory changes.

For those with chronic conditions causing hyperpigmentation, regular monitoring helps detect changes early. Support groups and online communities provide valuable resources for managing the psychological impact of visible pigmentation changes.

The Bottom Line: Understanding Your Changing Pigmentation

Darkening of gums and skin can result from numerous factors, ranging from benign genetic variations to underlying medical conditions requiring treatment. While most cases of hyperpigmentation are cosmetic concerns, sudden or widespread changes deserve medical evaluation to rule out systemic causes.

Understanding your body's baseline and monitoring changes helps distinguish normal variations from concerning developments. Whether your darkening stems from hormonal fluctuations, sun damage, medications, or other causes, effective treatments exist to address both the cosmetic and medical aspects of hyperpigmentation.

Remember that managing hyperpigmentation is often a marathon, not a sprint. With proper diagnosis, appropriate treatment, and consistent prevention strategies, most people can achieve significant improvement in their skin and gum appearance while addressing any underlying health concerns.

References

  1. Sarkar, R., Arora, P., & Garg, K. V. (2013). Cosmeceuticals for hyperpigmentation: What is available? Journal of Cutaneous and Aesthetic Surgery, 6(1), 4-11.[PubMed][DOI]
  2. Handel, A. C., Miot, L. D., & Miot, H. A. (2014). Melasma: a clinical and epidemiological review. Anais Brasileiros de Dermatologia, 89(5), 771-782.[PubMed][DOI]
  3. Nicolaidou, E., & Katsambas, A. D. (2014). Pigmentation disorders: hyperpigmentation and hypopigmentation. Clinics in Dermatology, 32(1), 66-72.[PubMed][DOI]
  4. Bornstein, S. R., Allolio, B., Arlt, W., et al. (2016). Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism, 101(2), 364-389.[PubMed][DOI]
  5. Dereure, O. (2001). Drug-induced skin pigmentation. Epidemiology, diagnosis and treatment. American Journal of Clinical Dermatology, 2(4), 253-262.[PubMed][DOI]
  6. Passeron, T., & Picardo, M. (2018). Melasma, a photoaging disorder. Pigment Cell & Melanoma Research, 31(4), 461-465.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my cortisol at home?

You can test your cortisol at home with SiPhox Health's Stress, Energy & Sleep Rhythm Cortisol test. This CLIA-certified test measures cortisol at three points throughout the day, providing insights into your adrenal function and stress response from the comfort of your home.

Is darkening of gums and skin always a sign of disease?

No, darkening is often benign and can result from genetic factors, hormonal changes, sun exposure, or medications. However, sudden or widespread darkening, especially with other symptoms like fatigue or weight loss, should be evaluated by a healthcare provider.

How long does it take for hyperpigmentation to fade with treatment?

Treatment timelines vary based on the cause and depth of pigmentation. Superficial darkening may improve within 3-6 months with consistent treatment, while deeper pigmentation can take 12 months or longer. Some medication-induced changes may take years to fully resolve.

Can vitamin deficiencies cause skin darkening?

Yes, certain vitamin deficiencies can contribute to pigmentation changes. Vitamin B12 deficiency can cause hyperpigmentation, while vitamin D deficiency may affect melanin production. Iron deficiency anemia can also lead to skin color changes.

Should I stop my medication if it's causing darkening?

Never stop prescribed medications without consulting your healthcare provider. They can assess whether the benefits outweigh the cosmetic concerns and may suggest alternatives or strategies to minimize pigmentation while continuing necessary treatment.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details